Objective response rate targets for recurrent glioblastoma clinical trials
Neuro-Oncology: The Podcast
English - March 17, 2023 13:35 - 31 minutes - 29.1 MB - ★★★★★ - 7 ratingsMedicine Health & Fitness Science Life Sciences neurology oncology tumors brain glioblastoma glioma lymphoma neurooncology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Mitotic count prognostic significance in IDH-mutant astrocytoma in the molecular era
Next Episode: Radiation therapy and structural brain changes
Dr. Maya Graham interviews Drs. Benjamin Ellingston and Timothy Cloughesy about their recently published manuscript entitled: "Objective response rate (ORR) targets for recurrent glioblastoma clinical trials based on the historic association between ORR and median overall survival", published online in Neuro-Oncology in January 2023.